Latest On Allergan plc (AGN):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-09-26 04:05 EST | Financials | Company financials have been released. | Neutral |  |
| 2020-07-31 00:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 15:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 16:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-12 06:30 EST | Insider Trade | Joseph H Boccuzi has directly disposed of 3,605 shares and currently holds 0 shares. | Sell | |
| 2020-05-12 06:30 EST | Insider Trade | Nesli Basgoz has directly disposed of 6,889 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 22:30 EST | Insider Trade | MATTHEW M WALSH has directly disposed of 12,039 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 22:30 EST | Insider Trade | THOMAS C FREYMAN has directly disposed of 2,983 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 22:30 EST | Insider Trade | A Robert D Bailey has directly disposed of 17,629 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 22:30 EST | Insider Trade | Adriane M Brown has directly disposed of 2,916 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 22:30 EST | Insider Trade | James DArecca has directly disposed of 3,511 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 22:30 EST | Insider Trade | CHRIS W BODINE has directly disposed of 18,615 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 22:30 EST | Insider Trade | ROBERT J HUGIN has directly disposed of 4,294 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 21:45 EST | Insider Trade | CHRISTOPHER J COUGHLIN has directly disposed of 16,532 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 21:45 EST | Insider Trade | CHRISTOPHER J COUGHLIN has disposed of 9,538 shares indirectly via family trust. | Sell | |
| 2020-05-11 21:45 EST | Insider Trade | CHRISTOPHER J COUGHLIN has disposed of 471 shares indirectly via grantor retained annuity trust. | Sell | |
| 2020-05-11 21:45 EST | Insider Trade | BRENT L SAUNDERS has directly disposed of 149,384 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 21:45 EST | Insider Trade | Peter J McDonnell has directly disposed of 6,352 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 21:45 EST | Insider Trade | William Meury has directly disposed of 7,434 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 21:45 EST | Insider Trade | Michael Eldon Greenberg has directly disposed of 1,693 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 21:45 EST | Insider Trade | C. David Nicholson has directly disposed of 9,999 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 21:45 EST | Insider Trade | Wayne R Swanton has directly disposed of 8,915 shares and currently holds 0 shares. | Sell | |
| 2020-05-11 21:45 EST | Insider Trade | CAROL ANTHONY DAVIDSON has directly disposed of 2,105 shares and currently holds 0 shares. | Sell | |
| 2020-05-10 08:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-10 06:14 EST | News | AbbVie finalizes Allergan takeover | N/A | |
| 2020-05-07 01:39 EST | News | FDA OKs Galderma lip filler | N/A | |
| 2020-05-07 01:37 EST | News | AbbVie deal for Allergan wins antitrust approval | N/A | |
| 2020-05-07 01:32 EST | News | DexCom +4.3% on move to S&P 500; Domino's moves up | N/A | |
| 2020-05-03 08:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-25 12:03 EST | Analyst Rating | The Analyst Target Price has increased from $188.17 to $188.33. | Buy | |
| 2020-04-23 10:40 EST | News | UBS softens view on Eli Lilly in premarket analyst action | N/A | |
| 2020-04-15 05:41 EST | Dividend | A dividend of $0.74 has been announced on Mar 18, 2020. It will be paid Jun 15, 2020 with an ex-dividend date of Apr 15, 2020. | Neutral | |
| 2020-04-14 04:03 EST | Analyst Rating | The Analyst Target Price has decreased from $193.31 to $188.17. | Neutral | |
| 2020-04-11 00:44 EST | News | Allergan EPS beats by $0.69, beats on revenue | N/A | |
| 2020-04-11 00:44 EST | News | Allergan Q4 revenues up 7%; Vraylar sales up 88% | N/A | |
| 2020-04-11 00:34 EST | News | CoolTone competitor sues Allergan over "false" advertising | N/A | |
| 2020-04-10 16:52 EST | News | Allergan and Editas Medicine dose first patient mid-stage study of blindness medicine | N/A | |
| 2020-04-10 16:51 EST | News | Evolus down 16.5% on "speculative" comments from Jeuveau competitor | N/A | |
| 2020-04-10 16:50 EST | News | FDA OKs Allergan eye implant for glaucoma | N/A | |
| 2020-04-10 16:39 EST | News | Teva launches Herceptin biosimilar in U.S. | N/A | |
| 2020-04-10 16:37 EST | News | AbbVie and Allergan ink agreement with FTC over divestment of certain assets | N/A | |
| 2020-04-10 16:37 EST | News | Allergan declares $0.74 dividend | N/A | |
| 2020-04-10 16:32 EST | News | AbbVie extends debt exchange offer to April 10 | N/A | |
| 2020-04-10 16:23 EST | News | EyeGate Pharma up 71% premarket on positive dry eye data | N/A | |
| 2020-04-10 16:17 EST | News | AbbVie extends debt exchange offer to April 24 | N/A | |
| 2020-04-08 04:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-08 00:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 00:03 EST | Analyst Rating | The Analyst Target Price has decreased from $193.85 to $193.31. | Neutral | |
| 2020-03-27 00:02 EST | Analyst Rating | The Analyst Target Price has decreased from $197.31 to $193.85. | Neutral | |
| 2020-03-20 23:15 EST | News | Which Stocks Are Vaccinated Against Pandemics? | N/A | |
About Allergan plc (AGN):
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, central nervous system, women's health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; In addition, it develops medical and cosmetic treatments; treatments for neurodegenerative disorders; and inflammatory and fibrotic diseases. It has a collaboration, option, and license agreement with Lyndra, Inc. to develop orally administered products for the treatment of Alzheimer's disease; strategic alliance and option agreement with Editas Medicine, Inc.; and Allergan plc also has licensing agreements with Assembly Biosciences, Inc. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was incorporated in 2013 and is headquartered in Dublin, Ireland. As of May 8, 2020, Allergan plc operates as a subsidiary of AbbVie Inc.
General
- Name Allergan plc
- Symbol AGN
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers—General
- Full Time Employees 17,400
- Last Split Factor2:1
- Last Split Date1997-10-30
- Fiscal Year EndDecember
- IPO Date1993-02-17
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.allergan.com
View More
Valuation
- Forward PE 11.89
- Price/Sales (Trailing 12 Mt.) 3.95
- Price/Book (Most Recent Quarter) 1.1
- Enterprise Value Revenue 5.04
- Enterprise Value EBITDA 28.44
View More
Financials
- Most Recent Quarter 2020-03-31
- Current Year EPS Estimate $16.11
- Next Year EPS Estimate $17.74
- Profit Margin -15%
- Operating Margin 7%
- Return on Assets 1%
- Return on Equity -4%
- Revenue 16.1 billion
- Earnings Per Share -$25.50
- Revenue Per Share $49.03
- Gross Profit 13.65 billion
- Quarterly Earnings Growth 0.2%
View More
ESG Rating
Highlights
- Market Capitalization 63.66 billion
- EBITDA 7.19 billion
- PEG Ratio 2.05
- Analyst Target Price $188.33
- Book Value Per Share $175.91
View More
Share Statistics
- Shares Outstanding 329.81 million
- Shares Float 329.6 million
- % Held by Insiders 16%
- % Held by Institutions 98.26%
- Shares Short 15.01 million
- Shares Short Prior Month 14.99 million
- Short Ratio 3.22
- Short % of Float 5%
- Short % of Shares Outstanding 5%
View More
Technicals
- Beta 1.2
- 52 Week High $202.22
- 52 Week Low $158.67
- 50 Day Moving Average 188.84
- 200 Day Moving Average 187.66
View More
Dividends
- Forward Annual Dividend Rate $2.96
- Forward Annual Dividend Yield 1.53%
- Dividend Date 2020-05-08
- ExDividend Date 2020-04-15
- Dividend Per Share $2.96
View More
Allergan plc (AGN) Dividend Calendar:
AGN's last dividend payment was made to shareholders on May 8, 2020.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|---|---|---|---|
| 2020-04-15 | 2020-06-15 | 2020-04-16 | 2020-03-18 | $0.74 |
| 2020-02-13 | 2020-03-13 | 2020-02-14 | 2020-01-24 | $0.74 |
| 2019-11-12 | 2019-12-13 | 2019-11-13 | 2019-10-25 | $0.74 |
| 2019-08-12 | 2019-09-13 | 2019-08-13 | 2019-07-19 | $0.74 |
| 2019-05-13 | 2019-06-14 | 2019-05-14 | 2019-05-03 | $0.74 |
| 2019-02-14 | 2019-03-15 | 2019-02-15 | 2019-01-25 | $0.74 |
| 2018-11-09 | 2018-12-14 | 2018-11-13 | 2018-10-26 | $0.72 |
| 2018-08-16 | 2018-09-17 | 2018-08-17 | 2018-07-30 | $0.72 |
| 2018-05-17 | 2018-06-15 | 2018-05-18 | 2018-05-03 | $0.72 |
| 2018-02-27 | 2018-03-28 | 2018-02-28 | 2018-02-09 | $0.72 |
| 2017-11-16 | 2017-12-15 | 2017-11-17 | 2017-10-27 | $0.7 |
| 2017-08-16 | 2017-09-15 | 2017-08-18 | 2017-08-02 | $0.7 |
| 2017-05-16 | 2017-06-15 | 2017-05-18 | 2017-05-05 | $0.7 |
| 2017-02-24 | 2017-03-28 | 2017-02-28 | 2017-02-03 | $0.7 |
Allergan plc (AGN) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2019-12-31 | 2019-12-31 | $4.35 billion | $5.22 | $4.57 | 14.22% |
| 2019-09-30 | 2019-09-30 | $4.05 billion | $4.25 | $4.22 | 0.71% |
| 2019-06-30 | 2019-06-30 | $4.09 billion | $4.38 | $4.35 | 0.69% |
| 2019-03-31 | 2019-03-31 | $3.6 billion | $3.79 | $3.55 | 6.76% |
| 2018-12-31 | 2019-01-29 | $4.08 billion | -$12.83 | $4.15 | -409.2% |
| 2018-09-30 | 2018-10-30 | $3.91 billion | -$0.11 | $4.04 | -102.77% |
| 2018-06-30 | 2018-07-26 | $4.12 billion | -$1.39 | $4.13 | -133.74% |
| 2018-03-31 | 2018-04-30 | $3.67 billion | -$0.99 | $3.36 | -129.57% |
| 2017-12-31 | 2018-02-06 | $4.33 billion | $8.68 | $4.74 | 83.11% |
| 2017-09-30 | 2017-11-01 | $4.03 billion | -$12.07 | $4.06 | -397.29% |
| 2017-06-30 | 2017-08-03 | $4.01 billion | -$2.37 | $3.92 | -160.54% |
| 2017-03-31 | 2017-05-09 | $3.57 billion | -$7.86 | $3.30 | -338.26% |
| 2016-12-31 | 2017-02-08 | $3.86 billion | -$0.20 | $3.76 | -105.23% |
| 2016-09-30 | 2016-11-02 | $3.62 billion | $38.58 | $3.56 | 983.71% |
| 2016-06-30 | 2016-08-08 | $3.68 billion | -$1.44 | $3.33 | -143.37% |
| 2016-03-31 | 2016-05-10 | $3.4 billion | $0.47 | ||
| 2015-12-31 | 2016-02-22 | $3.61 billion | -$1.78 | ||
| 2015-09-30 | 2015-11-04 | $3.47 billion | $13.29 | ||
| 2015-06-30 | 2015-08-06 | $3.63 billion | -$0.80 | ||
| 2015-03-31 | 2015-05-11 | $1.98 billion | -$1.85 | ||
| 2014-12-31 | 2015-02-18 | $2.42 billion | -$2.76 | ||
| 2014-09-30 | 2014-11-05 | $2.15 billion | -$3.95 | ||
| 2014-06-30 | 2014-08-05 | $2.17 billion | $0.28 | ||
| 2014-03-31 | 2014-04-30 | $2.6 billion | $0.55 | ||
| 2013-12-31 | 2014-02-20 | $2.78 billion | -$0.86 | ||
| 2013-09-30 | 2013-10-29 | $2.01 billion | $0.49 | ||
| 2013-06-30 | 2013-07-25 | $1.99 billion | -$4.27 | ||
| 2013-03-31 | 2013-05-02 | $1.9 billion | -$0.79 | ||
| 2012-12-31 | 2013-02-19 | $1.75 billion | $0.21 | ||
| 2012-09-30 | 2012-11-01 | $1.29 billion | $0.60 | ||
| 2012-06-30 | 2012-07-26 | $1.36 billion | -$0.49 | ||
| 2012-03-31 | 2012-04-30 | $1.52 billion | $0.43 | ||
| 2011-12-31 | 2012-02-14 | $1.54 billion | $0.75 | ||
| 2011-09-30 | 2011-11-01 | $1.08 billion | $0.54 | ||
| 2011-06-30 | 2011-07-26 | $1.08 billion | $0.42 | ||
| 2011-03-31 | 2011-04-27 | $869.1 million | $0.36 | ||
| 2010-12-31 | 2011-02-15 | $952.7 million | $0.15 | ||
| 2010-09-30 | 2010-11-04 | $882.4 million | $0.21 | ||
| 2010-06-30 | 2010-08-05 | $875.3 million | $0.57 | ||
| 2010-03-31 | 2010-05-10 | $856.5 million | $0.57 | ||
| 2009-12-31 | 2010-02-23 | $785.7 million | $0.51 | ||
| 2009-09-30 | 2009-11-04 | $662.1 million | $0.55 | ||
| 2009-06-30 | 2009-07-29 | $677.8 million | $0.46 | ||
| 2009-03-31 | 2009-04-30 | $667.4 million | $0.43 | ||
| 2008-12-31 | 2009-02-19 | $645.23 million | $0.50 | ||
| 2008-09-30 | 2008-10-29 | $640.69 million | $0.62 | ||
| 2008-06-30 | 2008-08-06 | $622.64 million | $0.53 | ||
| 2008-03-31 | 2008-05-01 | $626.95 million | $0.45 | ||
| 2007-12-31 | 2008-02-20 | $627.34 million | $0.34 | ||
| 2007-09-30 | 2007-11-06 | $594.71 million | $0.31 | ||
| 2007-06-30 | 2007-08-02 | $603.01 million | $0.33 | ||
| 2007-03-31 | 2007-05-02 | $671.61 million | $0.29 | ||
| 2006-12-31 | 2007-02-28 | $621.16 million | -$4.81 | ||
| 2006-09-30 | 2006-11-07 | $440.49 million | $0.31 | ||
| 2006-06-30 | 2006-08-08 | $510.36 million | -$0.15 | ||
| 2006-03-31 | 2006-05-09 | $407.23 million | $0.23 | ||
| 2005-12-31 | 2006-02-16 | $418.81 million | $0.18 | ||
| 2005-09-30 | 2005-11-02 | $410.3 million | $0.36 | ||
| 2005-06-30 | 2005-07-27 | $416.27 million | $0.35 | ||
| 2005-03-31 | 2005-05-05 | $400.83 million | $0.33 | ||
| 2004-12-31 | 2005-02-10 | $423.51 million | $0.46 | ||
| 2004-09-30 | 2004-10-27 | $408.02 million | $0.13 | ||
| 2004-06-30 | 2004-08-03 | $399.37 million | $0.32 | ||
| 2004-03-31 | 2004-04-29 | $409.66 million | $0.42 | ||
| 2003-12-31 | 2004-02-06 | $406.16 million | $0.48 | ||
| 2003-09-30 | 2003-11-05 | $358.76 million | $0.47 | ||
| 2003-06-30 | 2003-08-05 | $355.88 million | $0.47 | ||
| 2003-03-31 | 2003-05-06 | $336.92 million | $0.44 | ||
| 2002-12-31 | 2003-02-13 | $329.57 million | $0.40 | ||
| 2002-09-30 | 2002-11-06 | $307.86 million | $0.38 | ||
| 2002-06-30 | 2002-08-07 | $300.07 million | $0.56 | ||
| 2002-03-31 | 2002-05-08 | $285.69 million | $0.30 | ||
| 2001-12-31 | 2002-02-14 | $293.91 million | $0.43 | ||
| 2001-09-30 | 2001-11-13 | $270.94 million | -$0.55 | ||
| 2001-06-30 | 2001-06-30 | $298.98 million | $0.61 | ||
| 2001-03-31 | 2001-03-31 | $296.85 million | $0.58 | ||
| 2000-12-31 | 2000-12-31 | $254.76 million | -$0.13 | ||
| 2000-09-30 | 2000-09-30 | $179.33 million | -$0.56 | ||
| 2000-06-30 | 2000-06-30 | $200.2 million | $0.96 | ||
| 2000-03-31 | 2000-03-31 | $177.23 million | $1.48 | ||
| 1999-12-31 | 1999-12-31 | $0.75 | |||
| 1999-09-30 | 1999-09-30 | $0.38 | |||
| 1999-06-30 | 1999-06-30 | $0.47 | |||
| 1999-03-31 | 1999-03-31 | $0.23 | |||
| 1998-12-31 | 1998-12-31 | $0.40 | |||
| 1998-09-30 | 1998-09-30 | $0.37 | |||
| 1998-06-30 | 1998-06-30 | $0.36 | |||
| 1998-03-31 | 1998-03-31 | $0.13 |
Allergan plc (AGN) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Allergan plc (AGN) Chart:
Allergan plc (AGN) News:
Below you will find a list of latest news for Allergan plc (AGN) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Allergan plc (AGN) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Allergan plc (AGN) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-05-21 | 15-12B | Securities registration termination [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1578845/000119312520148719/0001193125-20-148719-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1578845/000083423720008774/0000834237-20-008774-index.htm |
| 2020-05-11 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret | https://www.sec.gov/Archives/edgar/data/1578845/000087666120000384/0000876661-20-000384-index.htm |
| 2019-02-21 | PX14A6G | Notice of exempt solicitation submitted by non-management | https://www.sec.gov/Archives/edgar/data/1578845/000089534519000112/0000895345-19-000112-index.htm |
| 2019-03-04 | PX14A6G | Notice of exempt solicitation submitted by non-management | https://www.sec.gov/Archives/edgar/data/1578845/000089534519000120/0000895345-19-000120-index.htm |
| 2019-03-07 | PX14A6G | Notice of exempt solicitation submitted by non-management | https://www.sec.gov/Archives/edgar/data/1578845/000089534519000124/0000895345-19-000124-index.htm |
| 2019-03-25 | PX14A6G | Notice of exempt solicitation submitted by non-management | https://www.sec.gov/Archives/edgar/data/1578845/000089534519000136/0000895345-19-000136-index.htm |
| 2019-04-05 | PX14A6G | Notice of exempt solicitation submitted by non-management | https://www.sec.gov/Archives/edgar/data/1578845/000089534519000147/0000895345-19-000147-index.htm |
| 2019-04-16 | PX14A6G | Notice of exempt solicitation submitted by non-management | https://www.sec.gov/Archives/edgar/data/1578845/000089534519000170/0000895345-19-000170-index.htm |
| 2019-04-22 | PX14A6G | Notice of exempt solicitation submitted by non-management | https://www.sec.gov/Archives/edgar/data/1578845/000089534519000175/0000895345-19-000175-index.htm |
| 2020-03-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320007719/0000899243-20-007719-index.htm |
| 2020-03-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320007721/0000899243-20-007721-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012725/0000899243-20-012725-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012730/0000899243-20-012730-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012731/0000899243-20-012731-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012735/0000899243-20-012735-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012739/0000899243-20-012739-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012740/0000899243-20-012740-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012742/0000899243-20-012742-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012746/0000899243-20-012746-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012747/0000899243-20-012747-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012750/0000899243-20-012750-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012754/0000899243-20-012754-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012755/0000899243-20-012755-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012758/0000899243-20-012758-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012759/0000899243-20-012759-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012762/0000899243-20-012762-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012764/0000899243-20-012764-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012768/0000899243-20-012768-index.htm |
| 2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000090342319000153/0000903423-19-000153-index.htm |
| 2019-03-21 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000090342319000157/0000903423-19-000157-index.htm |
| 2019-03-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1578845/000104746919001547/0001047469-19-001547-index.htm |
| 2019-03-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000110465919016839/0001104659-19-016839-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000110465919059814/0001104659-19-059814-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1578845/000110465920018521/0001104659-20-018521-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000114420419024034/0001144204-19-024034-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000114420419037749/0001144204-19-037749-index.htm |
| 2019-02-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019002126/0001179110-19-002126-index.htm |
| 2019-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019002128/0001179110-19-002128-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019002262/0001179110-19-002262-index.htm |
| 2019-03-06 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019003411/0001179110-19-003411-index.htm |
| 2019-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019003412/0001179110-19-003412-index.htm |
| 2019-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019003413/0001179110-19-003413-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019003505/0001179110-19-003505-index.htm |
| 2019-03-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019003597/0001179110-19-003597-index.htm |
| 2019-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019003698/0001179110-19-003698-index.htm |
| 2019-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019003702/0001179110-19-003702-index.htm |
| 2019-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019003785/0001179110-19-003785-index.htm |
| 2019-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019004796/0001179110-19-004796-index.htm |
| 2019-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019004797/0001179110-19-004797-index.htm |
| 2019-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019004798/0001179110-19-004798-index.htm |
| 2019-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019004799/0001179110-19-004799-index.htm |
| 2019-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019004800/0001179110-19-004800-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005396/0001179110-19-005396-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005399/0001179110-19-005399-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005401/0001179110-19-005401-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005403/0001179110-19-005403-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005409/0001179110-19-005409-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005413/0001179110-19-005413-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005414/0001179110-19-005414-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005415/0001179110-19-005415-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005416/0001179110-19-005416-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005417/0001179110-19-005417-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005489/0001179110-19-005489-index.htm |
| 2019-12-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019012537/0001179110-19-012537-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911019012770/0001179110-19-012770-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020000039/0001179110-20-000039-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020000041/0001179110-20-000041-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020000043/0001179110-20-000043-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020000045/0001179110-20-000045-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020000047/0001179110-20-000047-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020000049/0001179110-20-000049-index.htm |
| 2020-02-13 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020001568/0001179110-20-001568-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003037/0001179110-20-003037-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003039/0001179110-20-003039-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003040/0001179110-20-003040-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003041/0001179110-20-003041-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003042/0001179110-20-003042-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003043/0001179110-20-003043-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003044/0001179110-20-003044-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020004761/0001179110-20-004761-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020004762/0001179110-20-004762-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020004763/0001179110-20-004763-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020005443/0001179110-20-005443-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020005444/0001179110-20-005444-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020005445/0001179110-20-005445-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020005446/0001179110-20-005446-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020005447/0001179110-20-005447-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020005448/0001179110-20-005448-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020005449/0001179110-20-005449-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020005450/0001179110-20-005450-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020005451/0001179110-20-005451-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1578845/000117911020005452/0001179110-20-005452-index.htm |
| 2019-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312519044365/0001193125-19-044365-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312519057925/0001193125-19-057925-index.htm |
| 2019-02-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519057927/0001193125-19-057927-index.htm |
| 2019-03-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312519083731/0001193125-19-083731-index.htm |
| 2019-03-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519083737/0001193125-19-083737-index.htm |
| 2019-03-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519085293/0001193125-19-085293-index.htm |
| 2019-04-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519095747/0001193125-19-095747-index.htm |
| 2019-04-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519106599/0001193125-19-106599-index.htm |
| 2019-04-17 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519109160/0001193125-19-109160-index.htm |
| 2019-04-23 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519114871/0001193125-19-114871-index.htm |
| 2019-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312519130938/0001193125-19-130938-index.htm |
| 2019-05-23 | SD | https://www.sec.gov/Archives/edgar/data/1578845/000119312519155347/0001193125-19-155347-index.htm | |
| 2019-06-17 | 11-K | Annual report of employee stock purchase, savings and similar plans | https://www.sec.gov/Archives/edgar/data/1578845/000119312519174847/0001193125-19-174847-index.htm |
| 2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312519181327/0001193125-19-181327-index.htm |
| 2019-06-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519181328/0001193125-19-181328-index.htm |
| 2019-06-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519182667/0001193125-19-182667-index.htm |
| 2019-06-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519183380/0001193125-19-183380-index.htm |
| 2019-06-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519184369/0001193125-19-184369-index.htm |
| 2019-06-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519186207/0001193125-19-186207-index.htm |
| 2019-06-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519186217/0001193125-19-186217-index.htm |
| 2019-06-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519186222/0001193125-19-186222-index.htm |
| 2019-06-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519186225/0001193125-19-186225-index.htm |
| 2019-07-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519187511/0001193125-19-187511-index.htm |
| 2019-07-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519190597/0001193125-19-190597-index.htm |
| 2019-07-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519193306/0001193125-19-193306-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312519213617/0001193125-19-213617-index.htm |
| 2019-08-12 | PREM14A | Preliminary proxy statements relating to merger or acquisition | https://www.sec.gov/Archives/edgar/data/1578845/000119312519219047/0001193125-19-219047-index.htm |
| 2019-09-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312519242242/0001193125-19-242242-index.htm |
| 2019-09-11 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519242245/0001193125-19-242245-index.htm |
| 2019-09-16 | DEFM14A | Definitive proxy statement relating to merger or acquisition | https://www.sec.gov/Archives/edgar/data/1578845/000119312519245800/0001193125-19-245800-index.htm |
| 2019-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312519245824/0001193125-19-245824-index.htm |
| 2019-09-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312519257491/0001193125-19-257491-index.htm |
| 2019-09-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519257518/0001193125-19-257518-index.htm |
| 2019-10-03 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1578845/000119312519261654/0001193125-19-261654-index.htm |
| 2019-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312519267023/0001193125-19-267023-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312519284117/0001193125-19-284117-index.htm |
| 2020-01-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312520014823/0001193125-20-014823-index.htm |
| 2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312520060441/0001193125-20-060441-index.htm |
| 2020-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312520076200/0001193125-20-076200-index.htm |
| 2020-04-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312520113546/0001193125-20-113546-index.htm |
| 2020-04-29 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1578845/000119312520126525/0001193125-20-126525-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312520134315/0001193125-20-134315-index.htm |
| 2020-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312520137717/0001193125-20-137717-index.htm |
| 2020-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000119312520142800/0001193125-20-142800-index.htm |
| 2020-05-14 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1578845/000119312520142832/0001193125-20-142832-index.htm |
| 2020-05-14 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1578845/000119312520142836/0001193125-20-142836-index.htm |
| 2020-05-14 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1578845/000119312520142837/0001193125-20-142837-index.htm |
| 2020-05-14 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1578845/000119312520142838/0001193125-20-142838-index.htm |
| 2020-05-14 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1578845/000119312520142844/0001193125-20-142844-index.htm |
| 2020-05-14 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1578845/000119312520142845/0001193125-20-142845-index.htm |
| 2020-05-14 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1578845/000119312520142849/0001193125-20-142849-index.htm |
| 2020-05-14 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1578845/000119312520142867/0001193125-20-142867-index.htm |
| 2020-05-14 | POSASR | Post-effective Amendment to an automatic shelf registration statement | https://www.sec.gov/Archives/edgar/data/1578845/000119312520142875/0001193125-20-142875-index.htm |
| 2020-05-14 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1578845/000119312520142892/0001193125-20-142892-index.htm |
| 2020-05-14 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1578845/000119312520142895/0001193125-20-142895-index.htm |
| 2020-05-14 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1578845/000119312520142899/0001193125-20-142899-index.htm |
| 2020-05-21 | 15-12B | Securities registration termination [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1578845/000119312520148719/0001193125-20-148719-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1578845/000156459019016635/0001564590-19-016635-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1578845/000156459019030919/0001564590-19-030919-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1578845/000156459019040462/0001564590-19-040462-index.htm |
| 2020-02-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1578845/000156459020003950/0001564590-20-003950-index.htm |
| 2020-02-18 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1578845/000156459020005038/0001564590-20-005038-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1578845/000156459020022386/0001564590-20-022386-index.htm |
| 2020-05-18 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1578845/999999999520001178/9999999995-20-001178-index.htm |
| 2020-05-18 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1578845/999999999520001179/9999999995-20-001179-index.htm |
| 2020-05-18 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1578845/999999999520001180/9999999995-20-001180-index.htm |
| 2020-05-18 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1578845/999999999520001182/9999999995-20-001182-index.htm |
Allergan plc (AGN) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Allergan plc (AGN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 16%Institutional Ownership: 9826%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-05-08 | A Robert D Bailey | EVP Chief Legal Off & Corp Sec | Sell | 17,629.31 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012754/0000899243-20-012754-index.htm | ||
| 2020-05-08 | Adriane M Brown | Director | Sell | 2,916.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012755/0000899243-20-012755-index.htm | ||
| 2020-05-08 | BRENT L SAUNDERS | Chairman, President and CEO | Sell | 149,384.28 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012730/0000899243-20-012730-index.htm | ||
| 2020-05-08 | C. David Nicholson | EVP Chief R&D Officer | Sell | 9,999.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012740/0000899243-20-012740-index.htm | ||
| 2020-05-08 | CAROL ANTHONY DAVIDSON | Director | Sell | 2,105.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012746/0000899243-20-012746-index.htm | ||
| 2020-05-08 | CHRIS W BODINE | Director | Sell | 18,615.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012759/0000899243-20-012759-index.htm | ||
| 2020-05-08 | CHRISTOPHER J COUGHLIN | Director | Sell | 16,532.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012725/0000899243-20-012725-index.htm | ||
| 2020-05-08 | James DArecca | SVP Chief Accounting Officer | Sell | 3,511.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012758/0000899243-20-012758-index.htm | ||
| 2020-05-08 | Joseph H Boccuzi | Director | Sell | 3,605.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012764/0000899243-20-012764-index.htm | ||
| 2020-05-08 | MATTHEW M WALSH | EVP, Chief Financial Officer | Sell | 12,039.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012747/0000899243-20-012747-index.htm | ||
| 2020-05-08 | Michael Eldon Greenberg | Director | Sell | 1,693.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012739/0000899243-20-012739-index.htm | ||
| 2020-05-08 | Nesli Basgoz | Director | Sell | 6,888.91 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012768/0000899243-20-012768-index.htm | ||
| 2020-05-08 | Peter J McDonnell | Director | Sell | 6,352.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012731/0000899243-20-012731-index.htm | ||
| 2020-05-08 | ROBERT J HUGIN | Director | Sell | 4,294.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012762/0000899243-20-012762-index.htm | ||
| 2020-05-08 | THOMAS C FREYMAN | Director | Sell | 2,983.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012750/0000899243-20-012750-index.htm | ||
| 2020-05-08 | Wayne R Swanton | EVP, Global Operations | Sell | 8,915.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012742/0000899243-20-012742-index.htm | ||
| 2020-05-08 | William Meury | EVP & Chief Commercial Officer | Sell | 7,434.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012735/0000899243-20-012735-index.htm | ||
| 2020-03-02 | James DArecca | SVP Chief Accounting Officer | Buy | 3,611.00 | 193.84 | 699,956.24 | 10,552.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003042/0001179110-20-003042-index.htm |
| 2020-05-08 | CHRISTOPHER J COUGHLIN | Director | Sell | 9,538.00 | 16,542.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012725/0000899243-20-012725-index.htm | ||
| 2019-03-07 | BRENT L SAUNDERS | Chairman, President and CEO | Buy | 300.00 | 142.18 | 42,654.00 | 169,206.29 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019003505/0001179110-19-003505-index.htm |
| 2019-03-07 | BRENT L SAUNDERS | Chairman, President and CEO | Buy | 860.00 | 143.70 | 123,582.00 | 170,066.29 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019003505/0001179110-19-003505-index.htm |
| 2019-03-07 | BRENT L SAUNDERS | Chairman, President and CEO | Buy | 600.00 | 144.37 | 86,622.00 | 170,666.29 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019003505/0001179110-19-003505-index.htm |
| 2019-05-02 | CHRISTOPHER J COUGHLIN | Director | Buy | 2,064.00 | 145.33 | 299,961.12 | 17,080.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005489/0001179110-19-005489-index.htm |
| 2019-05-02 | CHRIS W BODINE | Director | Buy | 2,064.00 | 145.33 | 299,961.12 | 19,606.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005401/0001179110-19-005401-index.htm |
| 2020-03-02 | Wayne R Swanton | EVP, Global Operations | Buy | 8,770.00 | 193.84 | 1,699,976.80 | 21,164.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003043/0001179110-20-003043-index.htm |
| 2020-03-02 | BRENT L SAUNDERS | Chairman, President and CEO | Buy | 68,613.00 | 193.84 | 13,299,943.92 | 229,189.29 | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003037/0001179110-20-003037-index.htm |
| 2020-05-08 | CHRISTOPHER J COUGHLIN | Director | Sell | 471.00 | 26,080.00 | https://www.sec.gov/Archives/edgar/data/1578845/000089924320012725/0000899243-20-012725-index.htm | ||
| 2019-05-02 | Michael Eldon Greenberg | Director | Buy | 2,064.00 | 145.33 | 299,961.12 | 2,684.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005414/0001179110-19-005414-index.htm |
| 2019-05-02 | CAROL ANTHONY DAVIDSON | Director | Buy | 2,064.00 | 145.33 | 299,961.12 | 3,096.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005403/0001179110-19-005403-index.htm |
| 2020-03-02 | William Meury | EVP & Chief Commercial Officer | Buy | 21,667.00 | 193.84 | 4,199,931.28 | 33,490.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003041/0001179110-20-003041-index.htm |
| 2019-02-18 | ROBERT J HUGIN | Director | Buy | 426.00 | 139.07 | 59,243.82 | 3,426.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019002128/0001179110-19-002128-index.htm |
| 2020-03-02 | A Robert D Bailey | EVP Chief Legal Off & Corp Sec | Buy | 14,444.00 | 193.84 | 2,799,824.96 | 35,008.31 | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003040/0001179110-20-003040-index.htm |
| 2020-03-02 | C. David Nicholson | EVP Chief R&D Officer | Buy | 21,667.00 | 193.84 | 4,199,931.28 | 35,972.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003044/0001179110-20-003044-index.htm |
| 2019-05-02 | Adriane M Brown | Director | Buy | 2,064.00 | 145.33 | 299,961.12 | 3,907.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005409/0001179110-19-005409-index.htm |
| 2020-03-02 | MATTHEW M WALSH | EVP, Chief Financial Officer | Buy | 15,476.00 | 193.84 | 2,999,867.84 | 39,657.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911020003039/0001179110-20-003039-index.htm |
| 2019-05-02 | THOMAS C FREYMAN | Director | Buy | 2,064.00 | 145.33 | 299,961.12 | 3,974.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005413/0001179110-19-005413-index.htm |
| 2019-05-02 | Joseph H Boccuzi | Director | Buy | 2,064.00 | 145.33 | 299,961.12 | 4,596.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005399/0001179110-19-005399-index.htm |
| 2019-05-02 | ROBERT J HUGIN | Director | Buy | 2,064.00 | 145.33 | 299,961.12 | 5,285.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005415/0001179110-19-005415-index.htm |
| 2019-05-02 | Peter J McDonnell | Director | Buy | 2,064.00 | 145.33 | 299,961.12 | 7,343.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005417/0001179110-19-005417-index.htm |
| 2019-03-06 | James DArecca | SVP Chief Accounting Officer | Buy | 2,036.00 | 137.51 | 279,970.36 | 7,505.00 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019003597/0001179110-19-003597-index.htm |
| 2019-05-02 | Nesli Basgoz | Director | Buy | 2,064.00 | 145.33 | 299,961.12 | 8,206.91 | https://www.sec.gov/Archives/edgar/data/1578845/000117911019005396/0001179110-19-005396-index.htm |